Difference between revisions of "CNS5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(19 intermediate revisions by 2 users not shown)
Line 5: Line 5:
 
If empty (no name is present), please volunteer to create content for that disease!
 
If empty (no name is present), please volunteer to create content for that disease!
  
−
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
+
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
−
 
+
__TOC__
−
<br />
 
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
Line 19: Line 18:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|Astrocystoma, IDH-Mutant
+
|
 +
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
|Disease
 
|Disease
 
|Meenakshi Mehrotra
 
|Meenakshi Mehrotra
Line 30: Line 50:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
+
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 +
|Disease
 +
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
|6/7/2022
 
|6/7/2022
 
|
 
|
Line 39: Line 61:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
+
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 +
|Disease
 +
|Meenakshi Mehrotra
 
|
 
|
 
|
 
|
Line 46: Line 70:
 
|LS
 
|LS
 
|
 
|
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
+
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
 
|-
 
|-
−
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
+
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 +
|Disease
 +
|Scott Smith
 
|6/27/2023
 
|6/27/2023
 
|
 
|
−
|PENDING
+
|COMPLETE
 
|
 
|
 
|LS
 
|LS
Line 57: Line 83:
 
|2021 template added (page created 6/27/23)
 
|2021 template added (page created 6/27/23)
 
|-
 
|-
−
|Angiocentric Glioma||Disease||
+
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 66: Line 94:
 
|
 
|
 
|-
 
|-
−
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
+
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 75: Line 105:
 
|
 
|
 
|-
 
|-
−
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
+
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
−
|
+
|Disease
−
|
+
|Scott Smith
−
|
+
|5/3/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|LS
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
+
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 +
|Disease
 +
|Laveniya Satgunaseelan (Linda Cooley - previous version)
 
|
 
|
 
|
 
|
Line 93: Line 127:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
+
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 +
|Disease
 +
|Xiaolin (Lynn) Hu
 
|2/21/2022
 
|2/21/2022
 
|
 
|
Line 102: Line 138:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 +
|Disease
 +
|Madina Sukhanova
 
|10/28/2022
 
|10/28/2022
 
|
 
|
Line 111: Line 160:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Infant-Type Hemispheric Glioma||Disease||
+
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 118: Line 168:
 
|
 
|
 
|
 
|
−
|2021 template added
 
−
|-
 
−
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
 
−
|9/13/2022<br />
 
 
|
 
|
−
|PENDING
+
|
 +
|-
 +
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 +
|Disease
 +
|Jeremy Pulvers
 +
|9/13/2022<br />
 +
|
 +
|PENDING
 
|
 
|
 
|LS
 
|LS
Line 129: Line 182:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|High-Grade Astrocytoma with Piloid Features||Disease||
+
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 138: Line 193:
 
|
 
|
 
|-
 
|-
−
|Pleomorphic Xanthoastrocytoma||Disease||
+
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 147: Line 204:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Subependymal Giant Cell Astrocytoma||Disease||
+
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 156: Line 215:
 
|
 
|
 
|-
 
|-
−
|Chordoid Glioma||Disease||
+
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 165: Line 226:
 
|
 
|
 
|-
 
|-
−
|Astroblastoma, MN1-Altered||Disease||
+
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 174: Line 237:
 
|
 
|
 
|-
 
|-
−
|Ganglioglioma||Disease||Leila Moayed-Aloei
+
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 +
|Disease
 +
|Leila Moayed-Aloei
 
|6/30/2022
 
|6/30/2022
 
|
 
|
Line 183: Line 248:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Gangliocytoma||Disease||
+
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 192: Line 259:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 201: Line 281:
 
|
 
|
 
|-
 
|-
−
|Dysembryoplastic Neuroepithelial Tumour||Disease||
+
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 210: Line 292:
 
|
 
|
 
|-
 
|-
−
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
+
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 219: Line 303:
 
|
 
|
 
|-
 
|-
−
|Papillary Glioneuronal Tumour||Disease||
+
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 228: Line 314:
 
|
 
|
 
|-
 
|-
−
|Rosette-Forming Glioneuronal Tumour||Disease||
+
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 237: Line 325:
 
|
 
|
 
|-
 
|-
−
|Myxoid Glioneuronal Tumour||Disease||
+
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 246: Line 336:
 
|
 
|
 
|-
 
|-
−
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
+
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 +
|Disease
 +
|Laveniya Satgunaseelan
 +
|9/11/2024
 
|
 
|
 +
|Pending
 
|
 
|
 
|
 
|
 
|
 
|
 +
|Testing 9/2024 somatic template
 +
|-
 +
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Multinodular and Vacuolating Neuronal Tumour||Disease||
 
 
|
 
|
 
|
 
|
Line 261: Line 357:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
 
 
|
 
|
 
|
 
|
Line 271: Line 368:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Central Neurocytoma||Disease||
 
 
|
 
|
 
|
 
|
Line 282: Line 380:
 
|
 
|
 
|-
 
|-
−
|Extraventricular Neurocytoma||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 291: Line 402:
 
|
 
|
 
|-
 
|-
−
|Cerebellar Liponeurocytoma||Disease||
+
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 300: Line 413:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 309: Line 424:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 318: Line 435:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 327: Line 446:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 336: Line 457:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 345: Line 468:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 354: Line 479:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma||Disease||
+
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 363: Line 490:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma, MYCN-Amplified||Disease||
+
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 371: Line 499:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
−
|Myxopapillary Ependymoma||Disease||
+
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 381: Line 523:
 
|
 
|
 
|-
 
|-
−
|Subependymoma||Disease||
+
|[[CNS5:Subependymoma|Subependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 390: Line 534:
 
|
 
|
 
|-
 
|-
−
|Choroid Plexus Papilloma||Disease||
 
 
|
 
|
 +
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Atypical Choroid Plexus Papilloma||Disease||
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Choroid Plexus Carcinoma||Disease||
 
 
|
 
|
 
|
 
|
Line 417: Line 566:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
+
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
−
|9/20/21
+
|Disease
 
|
 
|
−
|COMPLETE
 
 
|
 
|
−
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 
−
|9/22/2022
 
−
|2021 template added
 
−
|-
 
−
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
 
 
|
 
|
 
|
 
|
Line 433: Line 576:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
 
 
|
 
|
 
|
 
|
Line 444: Line 588:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
====CHAPTER 4 (EMBRYONAL TUMOURS)====
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Medulloblastoma, Histologically Defined||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Atypical Teratoid/Rhabdoid Tumour||Disease||
+
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 +
|Disease
 +
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 +
|9/20/21
 +
|
 +
|COMPLETE
 +
|
 +
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 +
|9/22/2022
 +
|2021 template added
 +
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 471: Line 631:
 
|
 
|
 
|-
 
|-
−
|Cribriform Neuroepithelial Tumour||Disease||
+
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 480: Line 642:
 
|
 
|
 
|-
 
|-
−
|Embryonal Tumour with Multilayered Rosettes||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 489: Line 664:
 
|
 
|
 
|-
 
|-
−
|CNS Neuroblastoma, FOXR2-Activated||Disease||
+
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 498: Line 675:
 
|
 
|
 
|-
 
|-
−
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
+
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 507: Line 686:
 
|
 
|
 
|-
 
|-
−
|CNS Embryonal Tumour NEC/NOS||Disease||
+
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 516: Line 697:
 
|
 
|
 
|-
 
|-
−
|Pineocytoma||Disease||
+
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 525: Line 708:
 
|
 
|
 
|-
 
|-
−
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
+
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 534: Line 719:
 
|
 
|
 
|-
 
|-
−
|Pineoblastoma||Disease||
+
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 543: Line 730:
 
|
 
|
 
|-
 
|-
−
|Papillary Tumour of the Pineal Region||Disease||
+
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 552: Line 741:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
 
 
|
 
|
 +
====CHAPTER 5 (PINEAL TUMOURS)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Schwannoma||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Pineocytoma|Pineocytoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Neurofibroma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|
 
−
|-
 
−
|Perineurioma||Disease||
 
 
|
 
|
 
|
 
|
Line 586: Line 794:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Hybrid Nerve Sheath Tumours||Disease||
 
 
|
 
|
 
|
 
|
Line 597: Line 806:
 
|
 
|
 
|-
 
|-
−
|Malignant Melanotic Nerve Sheath Tumour||Disease||
+
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 606: Line 817:
 
|
 
|
 
|-
 
|-
−
|Malignant Peripheral Nerve Sheath Tumour||Disease||
+
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 615: Line 828:
 
|
 
|
 
|-
 
|-
−
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
 
 
|
 
|
 +
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Meningioma||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Schwannoma|Schwannoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Solitary Fibrous Tumour||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Neurofibroma|Neurofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Haemangiomas and Vascular Malformations||Disease||
 
 
|
 
|
 
|
 
|
Line 648: Line 870:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Perineurioma|Perineurioma]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|Haemangioblastoma||Disease||
 
 
|
 
|
 
|
 
|
Line 658: Line 881:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Rhabdomyosarcoma||Disease||
 
 
|
 
|
 
|
 
|
Line 669: Line 893:
 
|
 
|
 
|-
 
|-
−
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
+
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 677: Line 902:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
−
|CIC-Rearranged Sarcoma||Disease||
+
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 687: Line 926:
 
|
 
|
 
|-
 
|-
−
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
+
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 696: Line 937:
 
|
 
|
 
|-
 
|-
−
|Ewing Sarcoma||Disease||
 
 
|
 
|
 +
====CHAPTER 7 (MENINGIOMA)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Mesenchymal Chondrosarcoma||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Meningioma|Meningioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Chondrosarcoma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 
|
 
|
 +
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)====
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Chordoma||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
+
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 741: Line 1,001:
 
|
 
|
 
|-
 
|-
−
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
+
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 750: Line 1,012:
 
|
 
|
 
|-
 
|-
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
+
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 759: Line 1,023:
 
|
 
|
 
|-
 
|-
−
|Immunodeficiency-Associated CNS Lymphomas||Disease||
+
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 768: Line 1,034:
 
|
 
|
 
|-
 
|-
−
|Lymphomatoid Granulomatosis||Disease||
+
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 777: Line 1,045:
 
|
 
|
 
|-
 
|-
−
|Intravascular Large B-cell Lymphoma||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 786: Line 1,067:
 
|
 
|
 
|-
 
|-
−
|MALT Lymphoma of the Dura||Disease||
+
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 795: Line 1,078:
 
|
 
|
 
|-
 
|-
−
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
+
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 804: Line 1,089:
 
|
 
|
 
|-
 
|-
−
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
+
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
−
|7/2/2023
+
|Disease
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|MS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|T-cell and NK/T-cell Lymphomas||Disease||
 
 
|
 
|
 
|
 
|
Line 820: Line 1,099:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Erdheim-Chester Disease||Disease||
 
 
|
 
|
 
|
 
|
Line 831: Line 1,111:
 
|
 
|
 
|-
 
|-
−
|Rosai-Dorfman Disease||Disease||
+
|[[CNS5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 840: Line 1,122:
 
|
 
|
 
|-
 
|-
−
|Juvenile Xanthogranuloma||Disease||
 
 
|
 
|
 +
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Langerhans Cell Histiocytosis||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Histiocytic Sarcoma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 +
|Disease
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|Germ Cell Tumours of the CNS||Disease||
 
 
|
 
|
 
|
 
|
Line 876: Line 1,165:
 
|
 
|
 
|-
 
|-
−
|Adamantinomatous Craniopharyngioma||Disease||
 
 
|
 
|
 +
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Papillary Craniopharyngioma||Disease||
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
 
 
|
 
|
 
|
 
|
Line 903: Line 1,197:
 
|
 
|
 
|-
 
|-
−
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
+
!'''Disease'''
−
|
+
!'''Page Type'''
−
|
+
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 911: Line 1,215:
 
|
 
|
 
|
 
|
−
|-
 
−
|Pituitary Blastoma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Metastases to the Meninges||Disease||
 
 
|
 
|
 
|
 
|
Line 936: Line 1,240:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
 
 
|
 
|
 
|
 
|
Line 946: Line 1,251:
 
|
 
|
 
|
 
|
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
 
|-
 
|-
−
|Neurofibromatosis Type 2||Disease||
+
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 957: Line 1,263:
 
|
 
|
 
|-
 
|-
−
|Schwannomatosis||Disease||
+
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 +
|Disease
 +
|Jennie Thurston
 +
|7/2/2023
 +
|
 +
|PENDING
 +
|
 +
|MS
 +
|
 +
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
 +
|-
 +
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 966: Line 1,285:
 
|
 
|
 
|-
 
|-
−
|Von Hippel-Lindau Syndrome||Disease||
+
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 975: Line 1,296:
 
|
 
|
 
|-
 
|-
−
|Tuberous Sclerosis||Disease||
+
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 984: Line 1,307:
 
|
 
|
 
|-
 
|-
−
|Li-Fraumeni Syndrome||Disease||
+
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 992: Line 1,316:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
−
|Cowden Syndrome||Disease||
+
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,002: Line 1,340:
 
|
 
|
 
|-
 
|-
−
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
+
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
−
|7/2/2023
+
|Disease
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS
 
 
|
 
|
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
 
−
|8/22/2023
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS/MS
 
 
|
 
|
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
 
 
|
 
|
 
|
 
|
 +
|-
 
|
 
|
 +
====CHAPTER 11 (GERM CELL TUMOURS)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Rhabdoid Tumour Predisposition Syndrome||Disease||
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Carney Complex||Disease||
 
 
|
 
|
 
|
 
|
Line 1,047: Line 1,383:
 
|
 
|
 
|-
 
|-
−
|DICER1 Syndrome||Disease||Jennie Thurston
 
−
|7/2/2023
 
 
|
 
|
−
|PENDING
+
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
 
|
 
|
−
|LS
+
----
 
|
 
|
−
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
----
−
|-
 
−
|Familial Paraganglioma Syndromes||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Melanoma-Astrocytoma Syndrome||Disease||
+
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,074: Line 1,415:
 
|
 
|
 
|-
 
|-
−
|Familial Retinoblastoma||Disease||
+
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,083: Line 1,426:
 
|
 
|
 
|-
 
|-
−
|BAP1 Tumour Predisposition Syndrome||Disease||
+
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,092: Line 1,437:
 
|
 
|
 
|-
 
|-
−
|Fanconi Anaemia||Disease||
+
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,101: Line 1,448:
 
|
 
|
 
|-
 
|-
−
|ELP1-Medulloblastoma Syndrome||Disease||
+
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,110: Line 1,459:
 
|
 
|
 
|-
 
|-
−
|}<br />
+
!'''Disease'''
−
{| class="wikitable" style="margin:auto"
+
!'''Page Type'''
−
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
+
!'''<span style="color:#0070C0">Author'''
−
|-
 
−
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
 
 
!'''Date Assigned to Author'''
 
!'''Date Assigned to Author'''
 
!'''Target Completion Date'''
 
!'''Target Completion Date'''
 
!'''Author Content (Pending or Complete)'''
 
!'''Author Content (Pending or Complete)'''
−
!'''Date Completed by Author'''!!'''Associate Editor'''
+
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
−
|Disease
 
−
|Meenakshi Mehrotra
 
−
|6/25/2023
 
 
|
 
|
−
|PENDING
+
====CHAPTER 13 (METASTASES TO THE CNS)====
 
|
 
|
−
|Laveniya Satgunaseelan (LS)
+
----
 
|
 
|
−
|2021 template added
+
----
−
|-
 
−
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 
−
|Disease
 
−
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
−
|6/7/2022
 
 
|
 
|
−
|COMPLETE
+
----
 
|
 
|
−
|LS
+
----
 
|
 
|
−
|2021 template added
+
----
−
|-
 
−
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 
−
|Disease
 
−
|Meenakshi Mehrotra
 
 
|
 
|
 +
----
 
|
 
|
−
|PENDING
+
----
 
|
 
|
−
|LS
+
----
 
|
 
|
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
+
----
 
|-
 
|-
−
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
+
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 
|Disease
 
|Disease
−
|Scott Smith
 
−
|6/27/2023
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS
 
 
|
 
|
−
|2021 template added (page created 6/27/23)
+
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
+
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,177: Line 1,513:
 
|
 
|
 
|-
 
|-
−
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
−
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
+
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,199: Line 1,567:
 
|
 
|
 
|-
 
|-
−
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
+
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
|Disease
 
|Disease
−
|Laveniya Satgunaseelan (Linda Cooley - previous version)
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS
 
 
|
 
|
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 
−
|Disease
 
−
|Xiaolin (Lynn) Hu
 
−
|2/21/2022
 
 
|
 
|
−
|COMPLETE
 
 
|
 
|
−
|LS
 
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
+
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
−
|Madina Sukhanova
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|10/28/2022
+
|N/A
−
|
+
|N/A
−
|COMPLETE
+
|N/A
−
|
+
|N/A
−
|LS
+
|N/A
−
|
+
|N/A
−
|2021 template added
+
|N/A
 
|-
 
|-
−
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
+
!'''Disease'''
−
|Disease
+
!'''Page Type'''
−
|
+
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,241: Line 1,652:
 
|
 
|
 
|
 
|
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 
−
|Disease
 
−
|Jeremy Pulvers
 
−
|9/13/2022<br />
 
−
|
 
−
|PENDING
 
 
|
 
|
−
|LS
 
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
+
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,265: Line 1,666:
 
|
 
|
 
|-
 
|-
−
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
+
|[[CNS5:Carney_complex|Carney complex]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,272: Line 1,673:
 
|
 
|
 
|
 
|
−
|LS
 
 
|
 
|
−
|2021 template added
+
|
 +
|
 
|-
 
|-
−
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
+
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
−
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
+
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,298: Line 1,699:
 
|
 
|
 
|-
 
|-
−
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
+
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,309: Line 1,710:
 
|
 
|
 
|-
 
|-
−
|[[CNS5:Ganglioglioma|Ganglioglioma]]
+
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
−
|Disease
 
−
|Leila Moayed-Aloei
 
−
|6/30/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Subependymoma|Subependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 
−
|Disease
 
−
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 
−
|9/20/21
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 
−
|9/22/2022
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineocytoma|Pineocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Schwannoma|Schwannoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Neurofibroma|Neurofibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Perineurioma|Perineurioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Meningioma|Meningioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Chordoma|Chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 
−
|Disease
 
−
|Jennie Thurston
 
−
|7/2/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|MS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
−
|Disease
 
−
|Ngoni Faya (trainee) + Madina Sukhanova
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 
−
|Disease
 
−
|Jennie Thurston
 
−
|7/2/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 
−
|Disease
 
−
|Jennifer Laffin
 
−
|8/22/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS/MS
 
−
|
 
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Carney_complex|Carney complex]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 
−
|Disease
 
−
|Jennie Thurston
 
−
|7/2/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
 
 
|Disease
 
|Disease
 
|
 
|
Line 2,419: Line 1,720:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
Line 2,433: Line 1,745:
 
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]

Latest revision as of 08:53, 11 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 PENDING Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee), Shashi Shetty (mentor) 6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Meenakshi Mehrotra PENDING LS Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 COMPLETE LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease Scott Smith 5/3/2024 PENDING LS
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan (Linda Cooley - previous version) PENDING LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease Jeremy Pulvers 9/13/2022
 PENDING LS 2021 template added
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease Laveniya Satgunaseelan 9/11/2024 Pending Testing 9/2024 somatic template
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myxopapillary ependymoma Disease
Subependymoma Disease

CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease

CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City 9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease

CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease

CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease

CHAPTER 7 (MENINGIOMA)
Meningioma Disease

CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease

CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease

CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease

CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease

CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease

CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cowden syndrome Disease See DIG5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Constitutional mismatch repair deficiency syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=15428"